Global /India /Healthcare /Drug Manufacturers - General /538965

Concord Drugs Ltd.

538965 (CONCORD)

• BSE: 538965 • Delayed

85.03INR 2.2%

0.8916 USD

As of 12 July 2026, Concord Drugs Ltd. has a market cap of $11.74M USD, ranking #40488 globally and #3133 in India. It ranks #3599 in the Healthcare sector, and #1174 in the Drug Manufacturers - General industry.

Global Rank

40488

1d: -1

1w: -24

1m: -

Country Rank

3133

1d: 0

1w: -6

1m: -

Sector Rank

3599

1d: 0

1w: +5

1m: -

Industry Rank

1174

1d: 0

1w: 0

1m: -

Key Stats

Market Cap

$11.74MUSD

1.12B INR

Enterprise Value

$13.72MUSD

1.31B INR

Revenue (TTM)

$5.37MUSD

512.41M INR

EBITDA (TTM)

$421.67KUSD

40.21M INR

Net Income (TTM)

$59.32KUSD

5.66M INR

EBITDA Margin

7.8%

Profit Margin

1.1%

PE Ratio

187.1

PS Ratio

2.2

PB Ratio

3.3

EV/EBITDA

32.5

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Seelam Reddy open_in_new

Employees

250

Founded

1995

Website

concorddrugs.in open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.2%	-3.8%	18%	19%	21%	0.8%	170%	178%	137%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	538965 (CONCORD) Concord Drugs Ltd ISIN: INE858L01010 TV: TradingView: BSE: CONCORD SA: Stock Analysis: BOM: 538965 YF: Yahoo Finance: 538965.BO GF: Google Finance: BOM: 538965 BA: Barron's: 538965 MS: Morningstar: XBOM: 538965	85.03 INR	TV: TradingView: BSE: CONCORD SA: Stock Analysis: BOM: 538965 YF: Yahoo Finance: 538965.BO GF: Google Finance: BOM: 538965 BA: Barron's: 538965 MS: Morningstar: XBOM: 538965

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Concord Drugs Ltd.

Concord Drugs Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers tissue bio-adhesive products; ready-to-fill pellets and multiple unit pellets system; other drugs in the form of tablets, capsules, small volume parenterals, dry powders, syrups and suspension, and dry syrups; and hand sanitizers. The company was incorporated in 1995 and is based in Hyderabad, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$44.74B 4.27T INR 381K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.19B 1.73T INR 155K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.01B 1.43T INR 128K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.61B 1.11T INR 99K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.77B 931.67B INR 83K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.61B 916.53B INR 82K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 6M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 5M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 3M%	97.4	United States
Roche Holding AG SIX: RO	$317.7B 256.25B CHF 3M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.23B 215.59B GBP 2M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 2M%	15.1	United States

chevron_leftBack